{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:19:53Z","timestamp":1783703993261,"version":"3.55.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T00:00:00Z","timestamp":1360022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T00:00:00Z","timestamp":1360022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/nrgastro.2013.11","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T06:45:54Z","timestamp":1360046754000},"page":"187-194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Current management strategies and emerging treatments for functional dyspepsia"],"prefix":"10.1038","volume":"10","author":[{"given":"Michael","family":"Camilleri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Stanghellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,5]]},"reference":[{"key":"BFnrgastro201311_CR1","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/BF01303162","volume":"38","author":"DA Drossman","year":"1993","unstructured":"Drossman, D. A.  et al. U. S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig. Dis. Sci. 38, 1569\u20131580 (1993).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro201311_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2165\/00019053-199201050-00003","volume":"1","author":"O Nyren","year":"1992","unstructured":"Nyren, O.  et al. Economic costs of functional dyspepsia. Pharmacoeconomics 1, 312\u2013324 (1992).","journal-title":"Pharmacoeconomics"},{"key":"BFnrgastro201311_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1365-2036.2003.01706.x","volume":"18","author":"HB El Serag","year":"2003","unstructured":"El Serag, H. B. & Talley, N. J. Health-related quality of life in functional dyspepsia. Aliment. Pharmacol. Ther. 18, 387\u2013393 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1053\/j.gastro.2009.03.039","volume":"137","author":"P Aro","year":"2009","unstructured":"Aro, P.  et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III) criteria in a Swedish population-based survey. Gastroenterology 137, 94\u2013100 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201311_CR5","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","volume":"130","author":"J Tack","year":"2006","unstructured":"Tack, J.  et al. Functional gastroduodenal disorders. Gastroenterology 130, 1466\u20131479 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201311_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1542-3565(04)00454-9","volume":"2","author":"EJ Castillo","year":"2004","unstructured":"Castillo, E. J.  et al. A community based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin. Gastroenterol. Hepatol. 2, 985\u2013996 (2004).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201311_CR7","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1111\/j.1572-0241.2007.01381.x","volume":"102","author":"RS Choung","year":"2007","unstructured":"Choung, R. S.  et al. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am. J. Gastroenterol. 102, 1983\u20131989 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201311_CR8","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/gut.2007.137125","volume":"57","author":"R Bisschops","year":"2008","unstructured":"Bisschops, R.  et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut 57, 1495\u20131503 (2008).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR9","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1053\/gast.1996.v110.pm8612991","volume":"110","author":"V Stanghellini","year":"1996","unstructured":"Stanghellini, V.  et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 110, 1036\u20131042 (1996).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201311_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1053\/j.gastro.2004.05.030","volume":"127","author":"J Tack","year":"2004","unstructured":"Tack, J., Bisschops, R. & Sarnelli, G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 127, 1239\u20131255 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201311_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1542-3565(03)00130-7","volume":"1","author":"AJ Bredenoord","year":"2003","unstructured":"Bredenoord, A. J.  et al. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin. Gastroenterol. Hepatol. 1, 264\u2013272 (2003).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201311_CR12","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1136\/gut.2008.158162","volume":"57","author":"L Van Oudenhove","year":"2008","unstructured":"Van Oudenhove, L.  et al. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut 57, 1666\u20131673 (2008).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR13","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/gutjnl-2011-300474","volume":"61","author":"NA Koloski","year":"2012","unstructured":"Koloski, N. A.  et al. The brain\u2013gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 61, 1284\u20131290 (2012).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR14","unstructured":"Tack, J. & Talley, N. J. Functional dyspepsia\u2014symptoms, defintions and validity of the Rome III criteria. Nat. Rev. Gastroenterol. Hepatol. (in press)."},{"key":"BFnrgastro201311_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/ajg.2010.66","volume":"105","author":"J Tack","year":"2010","unstructured":"Tack, J. & Talley, N. J. Gastroduodenal disorders. Am. J. Gastroenterol. 105, 757\u2013763 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201311_CR16","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1053\/j.gastro.2005.09.019","volume":"129","author":"NJ Talley","year":"2005","unstructured":"Talley, N. J. & American Gastroenterological Association. American Gastroenterological Association Medical Position Statement: evaluation of dyspepsia. Gastroenterology 129, 1753\u20131755 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201311_CR17","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","volume":"100","author":"NJ Talley","year":"2005","unstructured":"Talley, N. J., Vakil, N. & Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am. J. Gastroenterol. 100, 2324\u20132337 (2005).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201311_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1155\/2005\/674607","volume":"19","author":"SJ Veldhuyzen van Zanten","year":"2005","unstructured":"Veldhuyzen van Zanten, S. J.  et al. Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) Clinical Management Tool. Can. J. Gastroenterol. 19, 285\u2013303 (2005).","journal-title":"Can. J. Gastroenterol."},{"key":"BFnrgastro201311_CR19","doi-asserted-by":"publisher","first-page":"e39173","DOI":"10.1371\/journal.pone.0039173","volume":"7","author":"H Khademi","year":"2012","unstructured":"Khademi, H.  et al. Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in patients with dyspepsia in a GI clinic: a 7-year cross-sectional study. PLoS ONE 7, e39173 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201311_CR20","first-page":"A4363","volume":"58","author":"HC Rolff","year":"2011","unstructured":"Rolff, H. C., Simonsen, L. R. & Rosenberg, J. Clinical findings confirm national guidelines regarding primary gastroscopy for upper gastrointestinal symptoms. Dan. Med. Bull. 58, A4363 (2011).","journal-title":"Dan. Med. Bull."},{"key":"BFnrgastro201311_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/gut.46.1.93","volume":"46","author":"NP Breslin","year":"2000","unstructured":"Breslin, N. P.  et al. Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut 46, 93\u201397 (2000).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner, P.  et al. Management of Helicobacter pylori infection\u2014the Maastricht IV\/ Florence Consensus Report. Gut 61, 646\u2013664 (2012).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0140-6736(00)02553-8","volume":"356","author":"A Lassen","year":"2000","unstructured":"Lassen, A., Pedersen, F. M., Bytzer, P. & Schaffalitzky de Muckadell, O. B. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomized trial. Lancet 356, 455\u2013460 (2000).","journal-title":"Lancet"},{"key":"BFnrgastro201311_CR24","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1053\/j.gastro.2005.03.004","volume":"128","author":"AC Ford","year":"2005","unstructured":"Ford, A. C.  et al. Helicobacter pylori \u201ctest and treat\u201d or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology 128, 1838\u20131844 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201311_CR25","doi-asserted-by":"crossref","unstructured":"Delaney, B.  et al. Initial management strategies for dyspepsia. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD001961. doi:10.1002\/14651858.CD001961.pub3 (2005).","DOI":"10.1002\/14651858.CD001961.pub3"},{"key":"BFnrgastro201311_CR26","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1136\/gut.2004.043570","volume":"53","author":"AT Lassen","year":"2004","unstructured":"Lassen, A. T., Hallas, J. & Schaffalitzky de Muckadell, O. B. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial. Gut 53, 1758\u20131763 (2004).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR27","unstructured":"National Institute for Clinical Excellence. Dyspepsia: Managing Dyspepsia in Adults in Primary Care \n                    [online]\n                    \n                  , (2004)."},{"key":"BFnrgastro201311_CR28","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/gut.2007.147728","volume":"57","author":"S Mahadeva","year":"2008","unstructured":"Mahadeva, S., Chia, Y. C., Vinothini, A., Mohazmi, M. & Goh, K. L. Cost-effectiveness of and satisfaction with a Helicobacter pylori \u201ctest and treat\u201d strategy compared with prompt endoscopy in young Asians with dyspepsia. Gut 57, 1214\u20131220 (2008).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR29","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","volume":"12","author":"NJ Talley","year":"1998","unstructured":"Talley, N. J.  et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment. Pharmacol. Ther. 12, 1055\u20131065 (1998).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000339111","volume":"86","author":"S Futagami","year":"2012","unstructured":"Futagami, S.  et al. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying. Digestion 86, 114\u2013121 (2012).","journal-title":"Digestion"},{"key":"BFnrgastro201311_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1017\/S0266462306051269","volume":"22","author":"DE Jarbol","year":"2006","unstructured":"Jarbol, D. E., Bech, M., Kragstrup, J., Havelund, T. & Schaffalitzky de Muckadell, O. B. Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care. Int. J. Technol. Assess. Health Care 22, 362\u2013371 (2006).","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"BFnrgastro201311_CR32","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.3748\/wjg.v12.i31.5010","volume":"12","author":"WH Hu","year":"2006","unstructured":"Hu, W. H.  et al. Comparison between empirical prokinetics, Helicobacter test-and-treat and empirical endoscopy in primary-care patients presenting with dyspepsia: a one-year study. World J. Gastroenterol. 12, 5010\u20135016 (2006).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201311_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00535-006-1818-x","volume":"41","author":"TL Ang","year":"2006","unstructured":"Ang, T. L.  et al. Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study. J. Gastroenterol. 41, 647\u2013653 (2006).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro201311_CR34","unstructured":"Moayyedi, P.  et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD001960. doi:10.1002\/14651858.CD001960.pub5 (2006)."},{"key":"BFnrgastro201311_CR35","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/ajg.2010.351","volume":"105","author":"YL Xiao","year":"2010","unstructured":"Xiao, Y. L.  et al. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria. Am. J. Gastroenterol. 105, 2626\u20132631 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201311_CR36","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1046\/j.1365-2036.2002.01306.x","volume":"16","author":"U Ladabaum","year":"2002","unstructured":"Ladabaum, U.  et al. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis. Aliment. Pharmacol. Ther. 16, 1491\u20131501 (2002).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR37","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1053\/gast.2002.33019","volume":"122","author":"B Spiegel","year":"2002","unstructured":"Spiegel, B., Vakil, N. & Ofman, J. Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology 122, 1270\u20131285 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201311_CR38","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1111\/j.1572-0241.2002.07123.x","volume":"97","author":"L Rabeneck","year":"2002","unstructured":"Rabeneck, L.  et al. A double-blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia. Am. J. Gastroenterol. 97, 3045\u20133051 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201311_CR39","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","volume":"127","author":"P Moayyedi","year":"2004","unstructured":"Moayyedi, P.  et al. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 127, 1329\u20131337 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201311_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cgh.2006.09.012","volume":"5","author":"WH Wang","year":"2007","unstructured":"Wang, W. H.  et al. Effects of proton pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin. Gastroenterol. Hepatol. 5, 178\u2013185 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201311_CR41","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3748\/wjg.v18.i13.1517","volume":"18","author":"M Sakaguchi","year":"2012","unstructured":"Sakaguchi, M.  et al. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia. World J. Gastroenterol. 18, 1517\u20131524 (2012).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201311_CR42","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1038\/ajg.2010.354","volume":"105","author":"V Stanghellini","year":"2010","unstructured":"Stanghellini, V. & Frisoni, C. Editorial: Reflux, dyspepsia, and Rome III (or Rome IV?). Am. J. Gastroenterol. 105, 2632\u20132634 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201311_CR43","doi-asserted-by":"crossref","unstructured":"Moayyedi, P.  et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD002096. doi:10.1002\/14651858.CD002096.pub5 (2006).","DOI":"10.1002\/14651858.CD002096.pub5"},{"key":"BFnrgastro201311_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1542-3565(04)00059-X","volume":"2","author":"F Mearin","year":"2004","unstructured":"Mearin, F.  et al. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clin. Gastroenterol. Hepatol. 2, 301\u2013308 (2004).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201311_CR45","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1046\/j.1365-2036.2002.01236.x","volume":"16","author":"BI Hallerback","year":"2002","unstructured":"Hallerback, B. I.  et al. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment. Pharmacol. Ther. 16, 959\u2013967 (2002).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR46","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/j.1572-0241.2007.01654.x","volume":"103","author":"N Vakil","year":"2008","unstructured":"Vakil, N.  et al. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am. J. Gastroenterol. 103, 1906\u20131919 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201311_CR47","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1056\/NEJMoa052639","volume":"354","author":"G Holtmann","year":"2006","unstructured":"Holtmann, G.  et al. A placebo-controlled trial of itopride in functional dyspepsia. N. Engl. J. Med. 354, 832\u2013840 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201311_CR48","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gut.2007.132449","volume":"57","author":"NJ Talley","year":"2008","unstructured":"Talley, N. J.  et al. Itopride in functional dyspepsia: results of two phase III multicenter, randomized, double-blind, placebo-controlled trials. Gut 57, 740\u2013746 (2008).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/gut.2003.035279","volume":"54","author":"J Arts","year":"2005","unstructured":"Arts, J., Caenepeel, P., Verbeke, K. & Tack, J. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut 54, 455\u2013460 (2005).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR50","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1046\/j.1365-2036.2000.00868.x","volume":"14","author":"NJ Talley","year":"2000","unstructured":"Talley, N. J.  et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment. Pharmacol. Ther. 14, 1653\u20131661 (2000).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR51","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/gut.52.11.1555","volume":"52","author":"A Foxx-Orenstein","year":"2003","unstructured":"Foxx-Orenstein, A., Camilleri, M., Stephens, D. & Burton, D. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut 52, 1555\u20131561 (2003).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR52","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cgh.2008.11.025","volume":"7","author":"J Arts","year":"2009","unstructured":"Arts, J.  et al. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping. Clin. Gastroenterol. Hepatol. 7, 432\u2013437 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201311_CR53","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1365-2982.2009.01261.x","volume":"21","author":"J Tack","year":"2009","unstructured":"Tack, J.  et al. A dose-ranging, placebo-controlled pilot trial of acotiamide in patients with functional dyspepsia. Neurogastroenterol. Motil. 21, 272\u2013280 (2009).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201311_CR54","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2982.2009.01449.x","volume":"22","author":"K Matsueda","year":"2010","unstructured":"Matsueda, K.  et al. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia\u2014100 mg t.i.d. is an optimal dosage. Neurogastroenterol. Motil. 22, 618\u2013e173 (2010).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201311_CR55","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/gutjnl-2011-301454","volume":"61","author":"K Matsueda","year":"2012","unstructured":"Matsueda, K.  et al. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 61, 821\u2013828 (2012).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR56","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2982.2012.01897.x","volume":"24","author":"H Kusunoki","year":"2012","unstructured":"Kusunoki, H.  et al. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. Neurogastroenterol. Motil. 24, 540\u2013545 (2012).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201311_CR57","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1517\/13543784.2011.562890","volume":"20","author":"J Tack","year":"2011","unstructured":"Tack, J. & Janssen, P. Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia. Expert Opin. Investig. Drugs 20, 701\u2013712 (2011).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"BFnrgastro201311_CR58","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s00535-005-1687-8","volume":"40","author":"M Hojo","year":"2005","unstructured":"Hojo, M.  et al. Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J. Gastroenterol. 40, 1036\u20131042 (2005).","journal-title":"J. Gastroenterol."},{"issue":"Suppl. 2","key":"BFnrgastro201311_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2036.2005.02473.x","volume":"21","author":"M Otaka","year":"2005","unstructured":"Otaka, M.  et al. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment. Pharmacol. Ther. 21 (Suppl. 2), 42\u201346 (2005).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","volume":"93","author":"H Mertz","year":"1998","unstructured":"Mertz, H.  et al. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am. J. Gastroenterol. 93, 160\u2013165 (1998).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201311_CR61","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1046\/j.1365-2036.2003.01469.x","volume":"17","author":"J Tack","year":"2003","unstructured":"Tack, J.  et al. Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment. Pharmacol. Ther. 17, 603\u2013608 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR62","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.cgh.2008.02.051","volume":"6","author":"LA van Kerkhoven","year":"2008","unstructured":"van Kerkhoven, L. A.  et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin. Gastroenterol. Hepatol. 6, 746\u2013752 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201311_CR63","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1046\/j.1365-2036.2001.01090.x","volume":"15","author":"TG Dinan","year":"2001","unstructured":"Dinan, T. G.  et al. A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia\u2014are central serotoninergic responses enhanced? Aliment. Pharmacol. Ther. 15, 1613\u20131618 (2001).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR64","first-page":"G373","volume":"276","author":"B Coulie","year":"1999","unstructured":"Coulie, B.  et al. Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am. J. Physiol. 276, G373\u2013G377 (1999).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201311_CR65","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/j.1365-2036.2008.03849.x","volume":"28","author":"L Van Oudenhove","year":"2008","unstructured":"Van Oudenhove, L., Kindt, S., Vos, R., Coulie, B. & Tack, J. Influence of buspirone on gastric sensorimotor function in man. Aliment. Pharmacol. Ther. 28, 1326\u20131333 (2008).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR66","first-page":"G130","volume":"284","author":"HJ Chial","year":"2003","unstructured":"Chial, H. J.  et al. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am. J. Physiol. 284, G130\u2013G137 (2003).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201311_CR67","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cgh.2012.06.036","volume":"10","author":"J Tack","year":"2012","unstructured":"Tack, J., Janssen, P., Masaoka, T., Farr\u00e9, R. & Van Oudenhove, L. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin. Gastroenterol. Hepatol. 10, 1239\u20131245 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201311_CR68","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1038\/ajg.2009.427","volume":"104","author":"H Miwa","year":"2009","unstructured":"Miwa, H.  et al. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am. J. Gastroenterol. 104, 2779\u20132787 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201311_CR69","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/gut.41.5.664","volume":"41","author":"NW Read","year":"1997","unstructured":"Read, N. W.  et al. Efficacy and safety of the peripheral \u03ba agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 41, 664\u2013668 (1997).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR70","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1365-2036.2008.03676.x","volume":"27","author":"NJ Talley","year":"2008","unstructured":"Talley, N. J.  et al. Asimadoline, a \u03ba-opioid agonist, and satiation in functional dyspepsia. Aliment. Pharmacol. Ther. 27, 1122\u20131131 (2008).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR71","doi-asserted-by":"crossref","unstructured":"Soo, S.  et al. Psychological interventions for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD002301. doi:10.1002\/14651858.CD002301.pub5 (2005).","DOI":"10.1002\/14651858.CD002301.pub5"},{"key":"BFnrgastro201311_CR72","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0022-3999(94)90026-4","volume":"38","author":"TT Haug","year":"1994","unstructured":"Haug, T. T., Wilhelmsen, I., Svebak, S., Berstad, A. & Ursin, H. Psychotherapy in functional dyspepsia. J. Psychosom. Res. 38, 735\u2013744 (1994).","journal-title":"J. Psychosom. Res."},{"key":"BFnrgastro201311_CR73","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1053\/gast.2000.16493","volume":"119","author":"J Hamilton","year":"2000","unstructured":"Hamilton, J.  et al. A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 119, 661\u2013669 (2000).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201311_CR74","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1053\/gast.2002.37071","volume":"123","author":"EL Calvert","year":"2002","unstructured":"Calvert, E. L., Houghton, L. A., Cooper, P., Morris, J. & Whorwell, P. J. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 123, 1778\u20131785 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201311_CR75","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.gtc.2007.07.001","volume":"36","author":"M Camilleri","year":"2007","unstructured":"Camilleri, M. Functional dyspepsia: mechanisms of symptom generation and appropriate management of patients. Gastroenterol. Clin. North Am. 36, 649\u2013664 (2007).","journal-title":"Gastroenterol. Clin. North Am."},{"key":"BFnrgastro201311_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2036.2012.05128.x","volume":"36","author":"BE Lacy","year":"2012","unstructured":"Lacy, B. E.  et al. Review article: current treatment options and management of functional dyspepsia. Aliment. Pharmacol. Ther. 36, 3\u201315 (2012).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201311_CR77","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1365-2982.2002.00326.x","volume":"14","author":"HJ Chial","year":"2002","unstructured":"Chial, H. J.  et al. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol. Motil. 14, 249\u2013253 (2002).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201311_CR78","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1572-0241.2007.01636.x","volume":"103","author":"TL Abell","year":"2008","unstructured":"Abell, T. L.  et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the Society of Nuclear Medicine and the American Neurogastroenterology and Motility Society. Am. J. Gastroenterol. 103, 753\u2013763 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201311_CR79","doi-asserted-by":"publisher","unstructured":"Camilleri, M.  et al. Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol. Motil. \n                    http:\/\/dx.doi.org\/10.1111\/j.1365-29822012.01972.x\n                    \n                  .","DOI":"10.1111\/j.1365-29822012.01972.x"},{"key":"BFnrgastro201311_CR80","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cgh.2008.01.009","volume":"6","author":"LA Szarka","year":"2008","unstructured":"Szarka, L. A.  et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin. Gastroenterol. Hepatol. 6, 635\u2013643 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201311_CR81","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1365-2982.2009.01283.x","volume":"21","author":"ST Odunsi","year":"2009","unstructured":"Odunsi, S. T.  et al. Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol. Motil. 21, 706\u2013738 (2009).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201311_CR82","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1136\/gut.51.6.781","volume":"51","author":"EP Bouras","year":"2002","unstructured":"Bouras, E. P.  et al. SPECT imaging of the stomach: comparison with barostat and effects of sex, age, body mass index, and fundoplication. Gut 51, 781\u2013786 (2002).","journal-title":"Gut"},{"key":"BFnrgastro201311_CR83","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/j.1365-2982.2009.01374.x","volume":"21","author":"S Kindt","year":"2009","unstructured":"Kindt, S.  et al. Relationship between symptom pattern, assessed by the PAGI-SYM\u00a9 questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Neurogastroenterol. Motil. 21, 1183\u2013e105 (2009).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201311_CR84","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1053\/j.gastro.2004.09.006","volume":"127","author":"S Delgado-Aros","year":"2004","unstructured":"Delgado-Aros, S.  et al. Contributions of gastric volumes and gastric emptying to meal size and post-meal symptoms in functional dyspepsia. Gastroenterology 127, 1685\u20131694 (2004).","journal-title":"Gastroenterology"}],"updated-by":[{"DOI":"10.1038\/nrgastro.2013.79","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T00:00:00Z","timestamp":1366675200000}}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.11","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:47:31Z","timestamp":1684468051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,5]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFnrgastro201311"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2013.11","relation":{"correction":[{"id-type":"doi","id":"10.1038\/nrgastro.2013.79","asserted-by":"object"}]},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,5]]},"assertion":[{"value":"5 February 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2013","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published online, the drug names in Figure 1 were displayed incorrectly. The error has been corrected for the HTML and PDF versions of the article.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M. Camilleri declares no competing interests. V. Stanghellini has acted as a speaker for Alfa Wassermann, Almirall, Angelini, Janssen, Shire, and Takeda. He has acted as a consultant for Alfa Wassermann, Almirall, Angelini, Aptalis, Ironwood Pharmaceuticals, Norgine, Shire and Takeda. He has received research support from Alfa Wassermann, Almirall, Aptalis, Italchimici, Norgine, Shire and Sofar.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}